EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Summary by AI ^BETAClose X

Dermapharm Holding SE has issued a preliminary announcement regarding the upcoming disclosure of its financial statements. The company will publish its Quarterly/Interim statement for the second half-year on November 13, 2025. This report, which will be available in both German and English on the company's investor relations website, is a key release of financial information. This announcement, made on November 5, 2025, informs investors of the impending availability of data that could influence the company's stock share price upon its publication.

Disclaimer*

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements
Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

05.11.2025 / 13:48 CET/CEST
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly/ Interim statement within the 2nd half-year

Language: German
Date of disclosure: November 13, 2025
Address: https://ir.dermapharm.de/de/investor-relations/finanzberichte-praesentationen/

Language: English
Date of disclosure: November 13, 2025
Address: https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/

05.11.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News